What is Mio Global?
Founded in 2000 and publicly listed on the Shenzhen Stock Exchange in 2016, Guangdong Lifesense Medical Electronics Co., Ltd. is dedicated to becoming a global leader in remote health monitoring. With over two decades of expertise, the company excels in the research, design, manufacturing, and sales of medical-grade remote health monitoring devices. Their comprehensive product portfolio includes smart electronic blood pressure monitors, blood glucose monitoring systems, health scales, ECG monitoring devices, over-the-counter hearing aids, and advanced smart wearables. Lifesense is distinguished by its superior design and product quality, catering to clients within the smart healthcare and wearable technology industries.
How much funding has Mio Global raised?
Mio Global has raised a total of $15.9M across 2 funding rounds:
Debt
$1.5M
Series B
$14.4M
Debt (2015): $1.5M with participation from Export Development Canada
Series B (2016): $14.4M led by HydraVentures
Key Investors in Mio Global
HydraVentures
Hydra Ventures, the corporate venture arm of adidas AG, focuses on new market opportunities in apparel, footwear, and sports-related areas, with a preference for companies possessing sustainable or socially responsible attributes.
Export Development Canada
Export Development Canada, established in 1944, provides risk management, secure financing, and working capital services, headquartered in Ottawa, Ontario, Canada.
What's next for Mio Global?
The substantial enterprise-level funding, including a recent major strategic investment, positions Guangdong Lifesense Medical Electronics Co., Ltd. for accelerated growth and market expansion. This capital infusion is expected to fuel further innovation in their remote health monitoring solutions and enhance their global reach. The company's established track record and focus on quality suggest a strategic direction towards solidifying its leadership in the burgeoning digital health and wearable technology markets.
See full Mio Global company page
